By proceeding, you agree to our Terms of Use and Privacy Policy.
Dr. Jenny Yang is heading Novo Nordisk’s external innovation in Asia Pacific. She is responsible for identification, evaluation, and collaboration of enabling technologies, new targets, and novel therapeutics from idea to phase 2 clinical POC.
Talks About #drugdiscovery #biochemistry
Preferred Locations #Asia
Forge Valuable Cross-border Partnerships at Chinabio® Partnering Forum. Engage with the Largest Network of Potential Partners to Accelerate Your Cross-border Strategies and Expand Your Reach into the China Market.
